NCT07885176 Deep Repetitive Transcranial Magnetic Stimulation in the Treatment of Tinnitus
| NCT ID | NCT07885176 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Regensburg |
| Condition | Tinnitus |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-09-19 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-09-19 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Study of the efficacy of different H-coils in chronic tinnitus. Hypothesis: Active Deep repetitive transcranial magnetic stimulation deeprTMS reduces tinnitus distress more effectively than placebo stimulation. Randomized, placebo-controlled, parallel-group study with three treatment arms; additional comparison with a historical rTMS control group.
Eligibility Criteria
Inclusion Criteria: * Chronic tinnitus (\> 6 months) * Moderate tinnitus burden-corresponding to a score of ≥ 18 on the Tinnitus Handicap Inventory * Stable medication regimen with psychoactive substances Exclusion Criteria: * Objective tinnitus * Severe and unstable internal medicine, neurological, and psychiatric comorbidities (particularly acute psychosis, severe depression, or substance dependence; epilepsy; brain tumor; encephalitis; history of traumatic brain injury) * Presence of contraindications for TMS (electrical implants or metallic objects in the body, such as a pacemaker or insulin pump) * Currently undergoing or planning to undergo tinnitus treatment during the study * Meniere's disease, otosclerosis, acoustic neuroma, or other clear-cut or treatment-requiring causes of tinnitus
Contact & Investigator
Stefan Schoisswohl, Prof. Dr. hum sc
PRINCIPAL INVESTIGATOR
Psychiatry and Psychotherapie University Regensburg
Frequently Asked Questions
Who can join the NCT07885176 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Tinnitus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07885176 currently recruiting?
Yes, NCT07885176 is actively recruiting participants. Contact the research team at stefan.schoisswohl@ukr.de for enrollment information.
Where is the NCT07885176 trial being conducted?
This trial is being conducted at Regensburg, Germany.
Who is sponsoring the NCT07885176 clinical trial?
NCT07885176 is sponsored by University of Regensburg. The principal investigator is Stefan Schoisswohl, Prof. Dr. hum sc at Psychiatry and Psychotherapie University Regensburg. The trial plans to enroll 60 participants.